QURE 24.38-14.73 (-37.7%)Uniqure N.V. -
QURE Uniqure N.V. -25.81-13.30 (-34.0%)
Premarket Decliner
QURE Uniqure N.V. -39.11+0.88+2.3%
Premarket:16.19-22.92 (-58.6%)
uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington's Disease Showing Continued Slowing of Disease Progression
Globe NewswireTue, 29-Sep 7:12 AM
QURE Uniqure N.V. -38.80+0.57 (+1.5%)
QURE Uniqure N.V. -38.62-4.14 (-9.7%)